CHAYEH SAUNDERS: Open Payments
NPI 1659841971 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,739 in 93 payments from 15 companies in 2025. Trend: 2023 $1,812 · 2024 $1,289 · 2025 $1,739
Food & beverage: $1,720Education: $20
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $505 |
| Janssen Biotech, Inc. | 19 | $367 |
| Madrigal Pharmaceuticals | 12 | $155 |
| PFIZER INC. | 8 | $148 |
| Aimmune Therapeutics, Inc. | 4 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $93 |
| Phathom Pharmaceuticals, Inc. | 4 | $69 |
| Novo Nordisk Inc | 2 | $59 |
| Gilead Sciences, Inc. | 3 | $58 |
| Ardelyx, Inc. | 2 | $45 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, ZENPEP, CREON, ENTYVIO, VELSIPITY, VOQUEZNA.
Industry payments across MD — which companies pay providers there.
